Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | SVP, GENERICS | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 75,534 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Sale · Disposed 3,162 · Balance 75,534 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 00:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 3,162 | $77.00 | $243,474.00 |
DisclosureSEC source: 0001846478-26-000015 · wk-form4_1786496247.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,534 Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,772 | $79.50 | $220,374.00 |
DisclosureSEC source: 0001846478-26-000013 · wk-form4_1778703345.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,696 Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:07 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 3,314 | $74.04 | $245,368.56 |
DisclosureSEC source: 0001846478-26-000010 · wk-form4_1773173229.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,468 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 23:45 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,060 | $76.50 | $157,590.00 |
DisclosureSEC source: 0001846478-26-000008 · wk-form4_1772667946.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,782 Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 22:58 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,221 | $73.90 | $164,131.90 |
DisclosureSEC source: 0001846478-26-000006 · wk-form4_1772492317.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,842 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:58 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 12,969 | $77.15 | $1,000,558.35 |
DisclosureSEC source: 0001846478-26-000006 · wk-form4_1772492317.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,063 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026. Read SEC document |
| February 14, 2026 Filed Feb 17, 2026 21:06 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,888 | $77.36 | $146,055.68 |
DisclosureSEC source: 0001846478-26-000004 · wk-form4_1771362392.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,094 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:06 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,775 | $76.70 | $136,142.50 |
DisclosureSEC source: 0001846478-26-000004 · wk-form4_1771362392.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,982 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,917 shares of restricted stock, the grant of which was previously reported on February 18, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,267 | $76.25 | $325,358.75 |
DisclosureSEC source: 0001846478-26-000002 · wk-form4_1771017077.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,757 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,873 | $86.53 | $508,190.69 |
DisclosureSEC source: 0001846478-25-000013 · wk-form4_1755207996.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,024 F1 · price: The shares were sold in multiple trades at prices ranging from $86.50 to $86.79. The price reported above reflects the weighted average sales price. Read SEC document |
| May 15, 2025 Filed May 16, 2025 20:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 881 | $60.07 | $52,921.67 |
DisclosureSEC source: 0001846478-25-000011 · wk-form4_1747429059.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,897 F1 · price: The shares were sold in multiple trades at prices ranging from $60.06 to $60.09. The price reported above reflects the weighted average sales price. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:19 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 3,314 | $60.62 | $200,894.68 |
DisclosureSEC source: 0001846478-25-000009 · wk-form4_1741987175.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,778 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 300 | $31.49 Strike: $31.49 | $9,447.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · derivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,204 Underlying: Common Stock · 300 shares Expires 2031-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,084 | $60.00 | $305,040.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,092 F1 · price: The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 300 | $60.03 | $18,009.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,176 Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 21:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 300 | $31.49 | $9,447.00 |
DisclosureSEC source: 0001846478-25-000007 · wk-form4_1741381758.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:07 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,570 | $61.89 | $97,167.30 |
DisclosureSEC source: 0001846478-25-000005 · wk-form4_1741126058.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,176 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 01:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,167 | $58.92 | $68,759.64 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,746 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,227 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,426 | $58.92 | $84,019.92 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,913 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 10,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,339 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 15,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-25-000003 · wk-form4_1739927699.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,895 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| June 05, 2024 Filed Jun 6, 2024 22:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,985 | $67.00 | $199,995.00 |
DisclosureSEC source: 0001846478-24-000011 · wk-form4_1717712497.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,227 Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 02:21 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,494 | $66.71 | $166,374.74 |
DisclosureSEC source: 0001846478-24-000009 · wk-form4_1709864464.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,212 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:03 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,570 | $67.67 | $106,241.90 |
DisclosureSEC source: 0001846478-24-000007 · wk-form4_1709330627.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,706 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,342 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,244 | $57.55 | $71,592.20 |
DisclosureSEC source: 0001846478-24-000005 · wk-form4_1708466883.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,276 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,227 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:38 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 9,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-24-000003 · wk-form4_1708119468.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,520 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:38 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 14,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001846478-24-000003 · wk-form4_1708119468.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,678 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 13,502 | $31.49 Strike: $31.49 | $425,177.98 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · derivative · entry 4 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,504 Underlying: Common Stock · 13,502 shares Expires 2031-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total options vested on each of February 15, 2022 and February 15, 2023. 25% of the total options will vest on each of February 15, 2024 and February 15, 2025. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,059 | $62.39 | $128,461.01 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 3 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,915 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.32 to $62.50, inclusive. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 13,502 | $62.39 | $842,389.78 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,974 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $62.31 to $62.68, inclusive. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:22 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 13,502 | $31.49 | $425,177.98 |
DisclosureSEC source: 0001846478-23-000002 · wk-form4_1692994951.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 586 | $44.23 | $25,918.78 |
DisclosureSEC source: 0001104659-23-030709 · tm239061-4_4seq1.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,027 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,756 | $44.23 | $77,667.88 |
DisclosureSEC source: 0001104659-23-030709 · tm239061-4_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,613 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 11,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041734 · tm2311710-5_4seq1.xml · nonDerivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,974 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 5, 2023 00:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 17,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-041734 · tm2311710-5_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,396 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:31 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,275 | $45.04 | $57,426.00 |
DisclosureSEC source: 0001104659-23-023303 · tm237192-1_4seq1.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,369 Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:38 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 6,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004412 · form4-04292022_030449.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,644 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 00:50 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 19,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003395 · form4-03282022_050327.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,168 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 00:23 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,167 | $40.25 | $46,971.75 |
DisclosureSEC source: 0001415889-22-001534 · form4-02172022_040250.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,740 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,226 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 01:58 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantStock Option (right to buy) · Derivative | 27,006 | $0.00 Strike: $31.49 | $0.00 |
DisclosureSEC source: 0001415889-21-000743 · form4-02172021_050211.xml · derivative · entry 2 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,006 Underlying: Common Stock · 27,006 shares Expires 2031-02-15 F2 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025. Read SEC document |
| February 15, 2021 Filed Feb 18, 2021 01:58 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 12,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-000743 · form4-02172021_050211.xml · nonDerivative · entry 1 Gutwerg Ori · CIK 0001846478 · SVP, GENERICS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,907 F1 · shares: Represents a restricted stock award that will vest as to 25% of the total shares on each of February 15, 2022, February 15, 2023, February 15, 2024 and February 15, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.